Genetic effects on susceptibility, clinical expression, and treatment outcome of type 1 autoimmune hepatitis
- 1 August 2002
- journal article
- research article
- Published by Elsevier in Clinics in Liver Disease
- Vol. 6 (3) , 707-725
- https://doi.org/10.1016/s1089-3261(02)00023-5
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- Autoimmune hepatitis in Brazilian patients is not linked to tumor necrosis factor α polymorphisms at position −308Journal of Hepatology, 2001
- A map of human genome sequence variation containing 1.42 million single nucleotide polymorphismsNature, 2001
- Tumour necrosis factor-a promoter polymorphisms in primary biliary cirrhosisJournal of Hepatology, 1999
- Natural T cells in the human liver: cytotoxic lymphocytes with dual T cell and natural killer cell phenotype and function are phenotypically heterogenous and include Vα24-JαQ and γδ T cell receptor bearing cellsHuman Immunology, 1999
- Cytokines and the liverJournal of Hepatology, 1997
- Polymerase chain reaction haplotyping using 3′ mismatches in the forward and reverse primers: application to the biallelic polymorphisms of tumor necrosis factor and lymphotoxin αTissue Antigens, 1997
- Chronic active autoimmune hepatitis in childrenHuman Immunology, 1994
- Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1Nature, 1993
- HLA and insulin-dependent diabetes. A protective perspectiveDiabetes, 1992
- Susceptibility to autoimmune chronic active hepatitis: Human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factorsHepatology, 1991